• On March 30, 2026, Option Care Health expanded its revolving credit facility by US$450 million to US$850 million and increased its share repurchase authorization to US$1 billion, while reaffirming its 2026 guidance.
• The move strengthens liquidity and signals management’s confidence in cash generation, giving the company more flexibility to fund growth and return capital to shareholders.
• We’ll now examine how the expanded US$1 billion buyback authorization reshapes Option Care Health’s investment narrative and risk‑reward profile.

Rare earth metals are the new gold rush. Find out which 26 stocks are leading the charge.

Option Care Health Investment Narrative Recap

To own Option Care Health, you need to believe in sustained demand for home and alternate site infusion, supported by payer and pharma partnerships and efficient capital allocation. The expanded US$850 million credit facility and US$1 billion buyback authorization help liquidity and capital return, but do not materially change the near term focus on executing guidance and managing reimbursement and margin pressures as the key catalyst and main risk.

The January 2026 increase in equity buyback authority to US$1,000 million now sits alongside the expanded credit facility, giving the company more tools to support its capital return plans while it invests in growth projects, M&A and technology that underpin its longer term earnings and cash flow ambitions.

Yet against this backdrop, investors should still be aware of how reimbursement pressure and payer consolidation could...

Option Care Health's narrative projects $7.0 billion revenue and $302.2 million earnings by 2029. This implies 7.5% yearly revenue growth and about a $94.6 million earnings increase from $207.6 million today.

Uncover how Option Care Health's forecasts yield a $40.09 fair value, a 46% upside to its current price.

Exploring Other Perspectives

Two Simply Wall St Community fair value estimates span a wide band, from about US$3.66 to US$40.09 per share, underlining how far opinions can differ. As you weigh these views against the company’s growing reliance on payer and pharma relationships, it is worth considering how future reimbursement terms could shape Option Care Health’s financial trajectory and exploring several perspectives before forming your own.

Explore 2 other fair value estimates on Option Care Health - why the stock might be worth as much as 46% more than the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Option Care Health research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Option Care Health research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Option Care Health's overall financial health at a glance.

Searching For A Fresh Perspective?

Our top stock finds are flying under the radar-for now. Get in early:

• Find 59 companies with promising cash flow potential yet trading below their fair value.
• Invest in the nuclear renaissance through our list of 93 elite nuclear energy infrastructure plays powering the global AI revolution.
• Capitalize on the AI infrastructure supercycle with our selection of the 36 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.